Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Ophthalmology|July 4, 2006
Correlation between hemifield visual field damage and corresponding parapapillary atrophy in normal-tension glaucomaJunko Kawano, Atsuo Tomidokoro, Chihiro Mayama, et al.
Anticancer Research|January 1, 2015
Differential impact of fosaprepitant on infusion site adverse events between cisplatin- and anthracycline-based chemotherapy regimensTakeo Fujii, Naoki Nishimura, Kevin Y Urayama, et al.
Breast Cancer (Tokyo, Japan)|June 28, 2020
Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in JapanHiroko Bando, Akemi Kataoka, Kentaro Tamaki, et al.
Breast Cancer Research and Treatment|June 5, 2016
Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapiesAkira I Hida, Yasuaki Sagara, Daisuke Yotsumoto, et al.
Clinical Breast Cancer|March 12, 2024
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero SubtypesReiki Nishimura, Yoshitaka Fujiki, Tetsuhiko Taira, et al.
Annals of Surgical Oncology|March 11, 2022
Satisfaction of Patients Who Received Breast-Conserving Surgery Using the Suture Scaffold Technique: A Single-Institution, Cross-Sectional StudyReiko Mitsueda, Anri Gen, Yoshitaka Fujiki, et al.
Breast Cancer (Tokyo, Japan)|February 18, 2025
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancerReiki Nishimura, Yasuaki Sagara, Reiko Mitsueda, et al.
Breast Cancer (Tokyo, Japan)|October 9, 2023
Long-term prognostic value of the GenesWell BCT score in Asian women with hormone receptor-positive/HER2-negative early breast cancerYoshitaka Fujiki, Masahiro Kashiwaba, Mutsumi Sato, et al.
Breast Cancer (Tokyo, Japan)|May 23, 2022
Characteristics, treatment trends, and long-term outcomes of Japanese patients with pregnancy-associated breast cancer (PABC)Akemi Kataoka, Takayuki Ueno, Hideko Yamauchi, et al.
Breast Cancer (Tokyo, Japan)|July 13, 2024
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probandsReiko Yoshida, Tomoko Kaneyasu, Arisa Ueki, et al.
Pageof 2